Vaccination with Recombinant Aspartic Hemoglobinase Reduces Parasitic Load and Blood Loss After Hookworm Infection in Dogs
Total Page:16
File Type:pdf, Size:1020Kb
Open access, freely available online PLoS MEDICINE Vaccination with Recombinant Aspartic Hemoglobinase Reduces Parasite Load and Blood Loss after Hookworm Infection in Dogs Alex Loukas1*, Jeffrey M. Bethony2, Susana Mendez2, Ricardo T. Fujiwara2, Gaddam Narsa Goud2, Najju Ranjit1, Bin Zhan2, Karen Jones2, Maria Elena Bottazzi2, Peter J. Hotez2* 1 Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia, 2 Department of Microbiology and Tropical Medicine, The George Washington University Medical Center, Washington, District of Columbia, United States of America Competing Interests: The authors have declared that no competing ABSTRACT interests exist. Background Author Contributions: AL, JMB, MEB, and PJH designed the study. Hookworms infect 730 million people in developing countries where they are a leading cause AL, RTF, GNG, NR, BZ, performed of intestinal blood loss and iron-deficiency anemia. At the site of attachment to the host, adult experiments. AL, PJH, JMB, SM, and hookworms ingest blood and lyse the erythrocytes to release hemoglobin. The parasites KJ analyzed the data. AL, PJH, JMB, and SM contributed to writing the subsequently digest hemoglobin in their intestines using a cascade of proteolysis that begins paper. with the Ancylostoma caninum aspartic protease 1, APR-1. Academic Editor: Maria Yazdanbakhsh, Leiden University Methods and Findings Medical Center, the Netherlands Citation: Loukas A, Bethony JM, We show that vaccination of dogs with recombinant Ac-APR-1 induced antibody and cellular Mendez S, Fujiwara RT, Goud GN, et responses and resulted in significantly reduced hookworm burdens (p ¼ 0.056) and fecal egg al. (2005) Vaccination with counts (p ¼ 0.018) in vaccinated dogs compared to control dogs after challenge with infective recombinant aspartic hemoglobinase reduces parasite larvae of A. caninum. Most importantly, vaccinated dogs were protected against blood loss (p ¼ load and blood loss after hookworm 0.049) and most did not develop anemia, the major pathologic sequela of hookworm disease. infection. PLoS Med 2(10): e295. IgG from vaccinated animals decreased the catalytic activity of the recombinant enzyme in vitro Received: April 8, 2005 and the antibody bound in situ to the intestines of worms recovered from vaccinated dogs, Accepted: July 13, 2005 implying that the vaccine interferes with the parasite’s ability to digest blood. Published: October 4, 2005 DOI: Conclusion 10.1371/journal.pmed.0020295 To the best of our knowledge, this is the first report of a recombinant vaccine from a Copyright: Ó 2005 Loukas et al. This is an open-access article distributed hematophagous parasite that significantly reduces both parasite load and blood loss, and it under the terms of the Creative supports the development of APR-1 as a human hookworm vaccine. Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abbreviations: APR-1, Ancylostoma caninum aspartic protease 1; AS03, GlaxoSmithKline Adjuvant System 01; ELISA, enzyme-linked immunosorbent assay; epg, eggs per gram of feces; Hb, hemoglobin; L3, third stage larvae *To whom correspondence should be addressed. E-mail: alex.loukas@ qimr.edu.au (AL); mtmpjh@gwumc. edu (PJH) PLoS Medicine | www.plosmedicine.org1008 October 2005 | Volume 2 | Issue 10 | e295 Vaccination with Hookworm Hemoglobinase Introduction and particularly fetal, Hb demands are considerable, render- ing these populations most vulnerable to the parasite [1]. Hookworms infect more than 700 million people in Here we describe vaccination of dogs with the aspartic tropical and subtropical regions of the world. The major hemoglobinase of A. caninum, Ac-APR-1 [21,23] and show that species infecting humans are Necator americanus and Ancylos- vaccination resulted in the production of neutralizing anti- toma duodenale. The parasites feed on blood, causing iron- bodies, significantly reduced egg counts, and significantly deficiency anemia, and as such, are a major cause of disease reduced adult worm burdens. Most importantly, Hb levels of burden in developing countries [1]. Unlike other human vaccinated dogs were significantly higher than those of dogs helminthiases, worm burdens do not generally decrease with that were vaccinated with adjuvant alone after parasite age; in fact, recent findings revealed that the heaviest worm challenge. These data show that aspartic hemoglobinases, burdens are found among the elderly [2,3]. Whereas particularly APR-1, are efficacious vaccines against canine anthelminthic chemotherapy with benzimidazole drugs is hookworm disease, providing strong support for further effective in eliminating existing adult parasites, re-infection investigation and development of APR-1 as a recombinant occurs rapidly after treatment [4], making a vaccine against vaccine against human hookworm disease. hookworm disease a desirable goal. Canines can be successfully vaccinated against infection Methods with the dog hookworm, Ancylostoma caninum, by immunization with third-stage infective larvae (L3) that have been attenu- Expression of Recombinant Ac-APR-1 in Pichia pastoris ated with ionizing radiation [5–7]. Subsequently, varying levels The entire open reading frame of Ac-APR-1 encoding the of vaccine efficacy have been reported for the major antigens zymogen (spanning Ser-17 to the C-terminal Phe-446) but secreted by hookworm L3 using hamsters [8,9] and dogs [10]. excluding the predicted signal peptide was cloned into the Despite obtaining encouraging levels of protection with larval expression vector pPIC-Za (Invitrogen, Carlsbad, California, antigens, only partial reductions in parasite load (fecal egg United States) using the XbaI and EcoRI sites. Yeast, P. pastoris counts and adult worm burdens) were reported. Moreover, X 33, was transformed with the vector encoding the Ac-APR-1 protective antigens from the larval stage are only expressed by zymogen as recommended by the manufacturer (Invitrogen) L3, and not adult worms, rendering antibodies against these with modifications. Protein disulfide isomerase (PDI) gene in L3 secretions useless against parasites that have successfully the vector pPIC3.5 (a gift from Mehmet Inan, University of reached adulthood in the gut and begun to feed on blood. We Nebraska, Lincoln, Nebraska, United States) was cut with SacI and transformed into P. pastoris X 33 cells which were already therefore suggest that an ideal hookworm vaccine would transformed with Ac-apr-1 following the manufacturer’s require a cocktail of two recombinant proteins, one targeting instructions. Eight transformed colonies were picked from the infective larva and the second targeting the blood-feeding YPD plates containing Geneticin (0.5–1.0 mgÁmlÀ1)and adult stage of the parasite [11]. Zeocin (1.0 mgÁmlÀ1) and tested for Ac-APR-1 expression Of the different families of proteins expressed by blood- following the manufacturer’s instructions. The highest feeding parasitic helminths, proteolytic enzymes have shown expressing colony was selected and transferred to suspension promise as intervention targets for vaccine development culture in flasks containing BMG medium (buffered minimal [12,13]. Proteases are pivotal for a parasitic existence, glycerol: 1.34% yeast nitrogen base, 0.00004% d-biotin, 1% w/ mediating fundamental physiologic processes such as molting, v glycerol, and 100 mM potassium phosphate, [pH 6.0]). tissue invasion, feeding, embryogenesis, and evasion of host Suspension cultures were then transferred to a Bioflo 3000 immune responses [12,14]. Parasite extracts enriched for fermentor (New Brunswick Scientific, Edison, New Jersey, proteases protect sheep against the blood-feeding nematodes United States) utilizing a 5-l vessel as described [8]. The Haemonchus contortus [15–18] and Ostertagia ostertagi [19]; how- recombinant protein was secreted into culture medium and ever, significant protective efficacy has not been shown with a affinity purified on nickel-agarose as described elsewhere [8]. purified recombinant protease from nematodes of livestock. Progress of purification was monitored using SDS-PAGE gels Hookworms feed by burying their anterior ends in the stained with Coomassie Brilliant Blue and immunoblots using intestinal mucosa of the host, rupturing capillaries and monoclonal antibodies to the vector-derived myc epitope. ingesting the liberated blood. Erythrocytes are lysed by pore Recombinant Ac-APR-1 was treated with PNGase F and O- formation [20], releasing hemoglobin (Hb) into the lumen of glycosidase, according to the manufacturer’s instructions the parasite’s intestine, where it is degraded by a semi- (Enzymatic CarboRelease kit; QA-Bio, San Mateo, California, ordered pathway of catalysis that involves aspartic, cysteine, United States), under denaturing conditions to remove any and metalloproteases [21]. Vaccination of dogs with a N-linked and O-linked oligosaccharides. Deglycosylation was catalytically active recombinant cysteine hemoglobinase, Ac- performed only to confirm the presence of N-linked sugars CP-2, induced antibodies that neutralized proteolytic activity on the recombinant molecule. All remaining studies were and provided partial protection to vaccinees by reducing egg conducted with the glycoprotein. output (a measure of intestinal worm burden) and worm size, but significant reductions of adult worm burdens and/or Activation and Hemoglobinolytic Activity of Recombinant blood loss